Matsuzawa T | Drug Evaluation Committee The Japan Pharmaceutical Manufacturers Association (jpma)
スポンサーリンク
概要
- Matsuzawa Toshiakiの詳細を見る
- 同名の論文著者
- Drug Evaluation Committee The Japan Pharmaceutical Manufacturers Association (jpma)の論文著者
関連著者
-
Matsuzawa T
Drug Evaluation Committee The Japan Pharmaceutical Manufacturers Association (jpma)
-
Matsuzawa Toshiaki
Safety Research Laboratories Of Yamanouchi Pharmaceutical Co. Ltd.
-
MATSUZAWA Toshiaki
Safety Research Laboratories, Yamanouchi Pharmaceutical Co., Ltd.
-
Hirabayashi Yoko
Division Of Cellular And Molecular Toxicology Kangwon National University
-
Hayashi Yuzo
Department Of Pharmaceutical Sciences Kitasato University
-
Nomura Mamoru
イナリサーチ
-
Nakamura Miho
Drug Safety Research Laoboratory Daiichi Pharmaceutical Co. Ltd.
-
Nomura M
Clinical Pathology Working Group The Japan Pharmaceutical Manufacturers Association
-
Nomura Mamoru
Drug Safety Research Laboratory Dai-ichi Pharmaceutical Co.ltd.
-
Hayashi Y
Department Of Pharmaceutical Sciences Kitasato University
-
Hayashi Y
Department Of Pathology Tokyo Metropolitan Komagome Hospital
-
Nakamura Miho
Drug Safety Research Center Developmental Research Laboratories Daiichi Pharmaceutical Co. Ltd.
-
Nomura Mamoru
Japan Pharmaceutical Manufactures Association (jpma):daiichi Pharmaceuticals Co.ltd
-
Umemura T
Division Of Pathology National Institute Of Health Sciences
-
KAWASAKI Yasushi
Div of Cellular and Molecular Toxicology
-
Kitamura Y
Division Of Pathology National Institute Of Health Sciences
-
Okazaki A
Safety Research Laboratories Yamanouchi Pharmaceutical Co. Ltd.
-
Okazaki Atsushi
Safety Research Laboratories Yamanouchi Pharmaceutical Co. Ltd.
-
PERKIN Chris
Bio-Research Laboratories Ltd.
-
FURUYA Tsuyoshi
Biological Safety Research Center, National Institute of Health Science
-
Unno Takashi
Kanebo.Ltd.
-
Matsuzawa Toshiaki
Yamanouchi Pharm.Co., Ltd.
-
Furuya Tsuyoshi
Biological Safety Research Center National Institute Of Health Science
-
HIRABAYASHI Yoko
Division of Cellular and Molecular Toxicology, Kangwon National University
-
Kitajima Satoshi
Department Of Environmental Health And Toxicology Tokyo Metropolitan Institute Of Public Health
-
Satoh Kanako
東京都健康安全研究センター 環境保健部
-
鈴木 博
理化学研究所仁科加速器研究センター川合理論物理学研究室
-
Sai-kato Kimie
Division Of Toxicology
-
Hayashi Y
National Inst. Health Sci. Tokyo
-
Sekita Kiyoshi
Division Of Cellular & Molecular Toxicology National Institute Of Health Sciences
-
Ono Atsushi
Toxicogenomics Project National Institute Of Biomedical Innovation:national Institute Of Health Scie
-
Ono Atsushi
Biological Safety Research Center National Institute Of Health Science
-
Hayashi Y
Division Of Pathology National Institute Of Health Sciences
-
TABATA HAJIME
Safety Research Laboratories, Yamanouchi Pharmaceutical Co., Ltd.
-
Tabata H
Safety Research Laboratories Yamanouchi Pharmaceutical Co. Ltd.
-
Tabata Hajime
Safety Research Laboratories Yamanouchi Pharmaceutical Co. Ltd.
-
Suzuki H
Meidensha Corp. Tokyo Jpn
-
Morita Nobuko
Sandoz Pharm.Ltd.
-
Hasegawa Hiroyuki
Taisho Pharm.Co., Ltd.
-
Suzuki Hisanori
Solid State Division Hamamatsu Photonics K.k.
-
HAYASHI Yutaka
Fujirebio
-
NOMURA Mamoru
Daiichi, JPMS
-
Suzuki H
Yamanashi University
-
Kodama Y
Biological Safety Research Center National Institute Of Health Science
-
SUZUKI Hiroshi
Safety Research Laboratories, Yamanouchi Pharmaceutical Co., Ltd.
-
Hirano Fumiya
Drug Evaluation Committee The Japan Pharmaceutical Manufacturers Association (jpma):research & D
-
Numa Toshiaki
Drug Evaluation Committee The Japan Pharmaceutical Manufacturers Association (jpma):toxicology Team
-
Endo Y
Drug Evaluation Committee The Japan Pharmaceutical Manufacturers Association (jpma):clinical Safety
-
ISHIKAWA Atsuko
Medicinal Safety Laboratories, Yamanouchi Pharmaceutical Co., Ltd.
-
OHATA Takeji
Medicinal Safety Laboratories, Yamanouchi Pharmaceutical Co., Ltd.
-
MATSUZAWA Toshiaki
Medicinal Safety Laboratories, Yamanouchi Pharmaceutical Co., Ltd.
-
Nishigaki K
Drug Evaluation Committee The Japan Pharmaceutical Manufacturers Association (jpma):fuji Research La
-
Ohata T
National Cancer Center Res. Inst. Tokyo
-
EAST Philip
Pharmaco LSR Ltd.
-
Sakai Hiroko
Safety Research Laboratories Yamanouchi Pharmaceutical Co. Ltd.
-
Nomura Mamoru
Daiichi Pharmaceutical Co.ltd
-
Mineshima H
Drug Safety Res. Laboratories (kakamigahara) Eisai Co. Ltd.
-
Ogasawara Hiroyuki
Drug Evaluation Committee The Japan Pharmaceutical Manufacturers Association (jpma):medical Research
-
ONO Chizuko
New Drug Development Research Center, Inc
-
Saito Minoru
Division Of Cellular & Molecular Toxicology National Institute Of Health Sciences
-
Saito Masako
Department Of Applied Physics University Of Tokyo:(present Address)institute For Solid State Physics
-
Nomura Mamoru
Drug Safety Research Laboratory Daiichi Pharmaceutical Co. Ltd.
-
Kurokawa Yuji
National Institute Of Health Sciences (formerly National Institute Of Hygienic Sciences)
-
Kurokawa Yuji
Biological Safety Research Center National Institute Of Health Sciences
-
Okuda Yasuyuki
Working Group For Reproductive Toxicology Non-clinical Evaluation Subcommitee Drug Evaluation Commit
-
Barker Michael
Huntingdon Research Centre Ltd.
-
Hoshino Kenji
Medicinal Safety Laboratories Yamanouchi Pharmaceutical Co. Ltd.
-
IKEGAMI Hisashi
Safety Research Laboratories, Yamanouchi Pharmaceutical Co., Ltd.
-
HAYASHI Yuzo
Biological Safety Research Center, National Institute of Health Sciences
-
SAKAI Toshiharu
Safety Research Laboratories, Yamanouchi Pharmaceutical Co., Ltd.
-
Okazaki Shuzo
Bozo Research Center, Inc. Gotemba Laboratory
-
SATO Michio
Div. of Medical Devices National Institute of Hygienic Sciences
-
HAYASHI Yutaka
Clinical Pathology Working Group, the Japan Pharmaceutical Manufacturers Association
-
NOMURA Mamoru
Clinical Pathology Working Group, the Japan Pharmaceutical Manufacturers Association
-
UNNO Takashi
Clinical Pathology Working Group, the Japan Pharmaceutical Manufacturers Association
-
IGARASHI Toshiji
Clinical Pathology Working Group, the Japan Pharmaceutical Manufacturers Association
-
SEKITA Kiyoshi
Biological Safety Research Center, National Institute of Health Science
-
Hayashi Yutaka
Fuji Rebio Inc.
-
Sekita Kiyoshi
National Institute of Health Sciences
-
Ono Atsushi
National Institute of Health Sciences
-
Furuya Tsuyoshi
National Institute of Health Sciences
-
Hayashi Yuzo
National Institute of Health Sciences
-
Kariya K
Kobe Gakuin University Faculty Of Pharmaceutical Sciences
-
Kariya Kimio
Faculty Of Pharmaceutical Sciences Kobegakuin University
-
Nomura Mamoru
Drug Safety Research Center Daiichi Pharmaceutical Co. Ltd.
-
HASEGAWA Hiroyuki
Taiho
-
SEKITA Seiji
NIHS.
-
SAITO Minoru
NIHS.
-
FURUYA Tsuyoshi
NIHS.
-
KUROKAWA Yuji
NIHS.
-
HAYASHI Yuzo
NIHS.
-
MORITA Nobuko
Sandz
-
OOBAYASHI Shigeo
Grelan
-
YAMAGUCHI Makiko
Up johon
-
Sakai Toshiharu
Safety Research Laboratories Product Development Laboratories Yamanouchi Pharmaceutical Co. Ltd.
-
Sakai Toshiharu
Medicinal Safety Laboratories Yamanouchi Pharmaceutical Co. Ltd.
-
Kodama Yukio
Division Of Cellular & Molecular Toxicology National Institute Of Health Sciences
-
Okazaki Shuzo
Bozo Research Center Inc.
-
Unno Takashi
Division Of Pathology National Institute Of Health Sciences
-
Umemura T
Hokkaido Univ. Sapporo Jpn
-
KUBO Michie
Safety Research Laboratories.Yamanouchi Pharmaceutical Co., Ltd.
-
Kubo Michie
Safety Research Laboratories Yamanouchi Pharmaceutical Co. Ltd.
-
Sugi M
Toin Univ. Yokohama Yokohama Jpn
-
Ono Chizuko
New Drug Development Research Center Inc.
-
Ono Chizuko
New Drug Development Research Center Inc
-
Unno Takashi
Japan Pharmaceutical Manufactures Association (jpma):kanebo Ltd
-
Wakata Akihiro
Medicinal Safety Laboratories Yamanouchi Pharmaceutical Co. Ltd.
-
East P
Eye Res. Centre Of Huntingdon Life Sci. Ltd. Suffolk Gbr
-
Igarashi T
Eisai Co. Ltd. Ibaraki Jpn
-
IMAMURA Kazunori
Medicinal Safety Laboratories, Yamanouchi Pharmaceutical Co., Ltd.
-
IWASAKI Makoto
Medicinal Safety Laboratories, Yamanouchi Pharmaceutical Co., Ltd.
-
Kawasaki Yasushi
Div.of Toxicol. National Institute Of Health Sciences
-
Ikegami Hisashi
Safety Research Laboratories Yamanouchi Pharmaceutical Co. Ltd.
-
Shimazu H
Bozo Research Center Inc.
-
MINESHIMA Hiroshi
Working Group for Reproductive Toxicology, Non-clinical Evaluation Subcommitee, Drug Evaluation Comm
-
NUMA Toshiaki
Working Group for Reproductive Toxicology, Non-clinical Evaluation Subcommitee, Drug Evaluation Comm
-
NISHIGAKI Keiji
Working Group for Reproductive Toxicology, Non-clinical Evaluation Subcommitee, Drug Evaluation Comm
-
ENDO Yoshihiko
Working Group for Reproductive Toxicology, Non-clinical Evaluation Subcommitee, Drug Evaluation Comm
-
OGASAWARA Hiroyuki
Working Group for Reproductive Toxicology, Non-clinical Evaluation Subcommitee, Drug Evaluation Comm
-
HIRANO Fumiya
Working Group for Reproductive Toxicology, Non-clinical Evaluation Subcommitee, Drug Evaluation Comm
-
MIYAKE Yukio
Working Group for Reproductive Toxicology, Non-clinical Evaluation Subcommitee, Drug Evaluation Comm
-
MATSUZAWA Toshiaki
Working Group for Reproductive Toxicology, Non-clinical Evaluation Subcommitee, Drug Evaluation Comm
-
SAKAI Hiroko
Safety Research Laboratories, Yamanouchi Pharmaceutical Co., Ltd.
-
FUJIWARA Michio
Medicinal Safety Laboratories, Yamanouchi Pharmaceutical Co., Ltd.
-
BARROW P.C.
Chrysalis
-
SHIMAZU Hiroshi
Bozo Research Center Inc.
-
PUTMAN D.L.
Microbiological Associates Inc.
-
SAN R.H.C.
Microbiological Associates Inc.
-
COUCH R.C.
Primate Research Institute of New Mexico State University
-
MINESHIMA Hiroshi
Drug Evaluation Committee, the Japan Pharmaceutical Manufacturers Association (JPMA)
-
ENDO Yoshihiko
Drug Evaluation Committee, the Japan Pharmaceutical Manufacturers Association (JPMA)
-
OGASAWARA Hiroyuki
Drug Evaluation Committee, the Japan Pharmaceutical Manufacturers Association (JPMA)
-
NISHIGAKI Keiji
Drug Evaluation Committee, the Japan Pharmaceutical Manufacturers Association (JPMA)
-
MATSUZAWA Toshiaki
Drug Evaluation Committee, the Japan Pharmaceutical Manufacturers Association (JPMA)
-
Barrow P
Chrysalis
-
Miyake Yukio
Working Group For Reproductive Toxicology Non-clinical Evaluation Subcommitee Drug Evaluation Commit
-
Fujiwara Michio
Toxicologic Pathology Drug Safety Res. Laboratories Astellas Pharma Inc.
-
Imamura K
Medicinal Safety Laboratories Yamanouchi Pharmaceutical Co. Ltd.
-
Nomura Mamoru
Drug Safety Research Cehter Developmental Research Lab. Daiichi Pharmaceutical Co. Ltd.
-
Iwasaki Makoto
Medicinal Safety Laboratories Yamanouchi Pharmaceutical Co. Ltd.
-
Unno Takashi
Clinical Pathology Working Group The Japan Pharmaceutical Manufacturers Association
-
Sekita Kiyoshi
Biological Safety Research Center National Institute Of Health Science
-
Igarashi Toshiji
Clinical Pathology Working Group The Japan Pharmaceutical Manufacturers Association
-
Umemura Takashi
Laboratory Of Comparative Pathology Graduate School Of Veterinary Medicine Hokkaido University
-
Hasegawa Hiroyuki
Taisho Pharm.co. Ltd.
-
Hayashi Yuzo
Biological Safety Research Center National Institute Of Hygienic Sciences
-
Kurokawa Yuji
National Institute Of Health Science Osaka Branch National Institute Of Health Sciences
-
Kurokawa Yuji
Biological Safety Research Center National Institute Of Health Science
著作論文
- A SURVEY OF THE VALUES OF CLINICAL CHEMISTRY PARAMETERS OBTAINED FOR A COMMON RAT BLOOD SAMPLE IN NINETY-EIGHT JAPANESE LABORATORIES
- INTRAVENOUS SINGLE AND REPEATED DOSE TOXICITY STUDIES OF CIMADRONATE (YM175), A NOVEL BISPHOSPHONATE, IN BEAGLE DOGS
- Sample surveillance for clinical pathology testing.
- Sample surveillance for clinical pathology testing(2) Analysis of blood chemical data
- BLOOD OF RATS AND DOGS FOR USE AS SURVEILLANCE SAMPLES : INVESTIGATION OF STORAGE AND TRANSPORTATION CONDITIONS
- THE EXACERBATING EFFECT OF INSULIN-INDUCED HYPOGLYCEMIA ON SPONTANEOUS PERIPHERAL NEUROPATHY IN AGED B6C3F1 MICE
- 21B-03-1 Clinical usefulness of 1,5-anhydroglucitol, fructosamine and hemoglobin A_ in mice
- SINGLE AND REPEATED INTRAVENOUS TOXICITY STUDIES OF PAMITEPLASE (GENETICAL RECOMBINATION) IN RATS AND MONKEYS
- REPRODUCTIVE TOXICITY MUTAGENICITY AND ANTIGENICITY OF PAMITFLPLASE (GENETICAL RECOMBINATION)
- Se2-2 How pharmaceutical companies meet the ICH guideline for reproductive toxicity studies. : Consideration from a survey carried out by JPMA(Proceedings of the 27th Annual Meeting)
- INTRAVENOUS SINGLE AND REPEATED DOSE TOXICITY STUDIES OF CIMADRONATE (YM175), A NOVEL BISPHOSPHONATE, IN RATS
- IMPACT OF GLOBALIZATION UNDER THE ICH GUIDELINES ON THE CONDUCT OF REPRODUCTIVE TOXICITY STUDIES : REPORT ON CURRENT STATUS IN JAPAN, EUROPE AND THE US BY QUESTIONNAIRE SURVEY
- INTRAVENOUS SINGLE AND REPEATED DOSE TOXICITY STUDIES OF CIMADRONATE (YM175), A NOVEL BISPHOSPHONATE, IN RATS